⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3383946 | 0.78 | — | — | |
| SCHEMBL215024 | 0.73 | — | — | |
| SCHEMBL5177022 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL442651 | 0.70 | — | — | |
| SCHEMBL4099773 | 0.70 | — | — | |
| SCHEMBL2799985 | 0.70 | — | — | |
| Water SCHEMBL5014877 | 0.70 | — | — | |
| SCHEMBL2992150 | 0.67 | — | — | |
| SCHEMBL4674240 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL2179660 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4222231-A1 | REVERSIBLE IMINE UV-ABSORBERS | The United States of America as represented by the Secretary of Agriculture (US) | 2023-08-09 | — | — | EP | disclosed |
| WO-2022072303-A1 | REVERSIBLE IMINE UV-ABSORBERS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2022-04-07 | — | — | WO | disclosed |
| US-20220098146-A1 | REVERSIBLE IMINE UV-ABSORBERS | METHOD PRODUCTS, PBC | 2022-03-31 | — | — | US | disclosed |
| EP-2895533-B1 | METHOD OF MAKING EXTRUDED SELF-CLUMPING GRANULAR ABSORBENT | PIONEER PET PRODUCTS LLC (US) | 2022-01-12 | — | — | EP | disclosed |
| US-20210290771-A1 | ENGINEERED RECEPTOR/LIGAND SYSTEM FOR DELIVERY OF THERAPEUTIC AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2021-09-23 | — | — | US | disclosed |
| CN-107821178-B | Method of making cat litter | 先锋宠物用品有限责任公司 | 2021-06-18 | — | — | CN | disclosed |
| US-11000597-B2 | Engineered receptor/ligand system for delivery of therapeutic agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2021-05-11 | — | — | US | disclosed |
| EP-3735826-A1 | EXTRUDED SELF-CLUMPING ANIMAL LITTER AND METHOD OF MAKING EXTRUDED SELF-CLUMPING ANIMAL LITTER | Pioneer Pet Products, LLC (US) | 2020-11-11 | — | — | EP | disclosed |
| EP-2894968-B1 | EXTRUDED SELF-CLUMPING ANIMAL LITTER AND METHOD OF MAKING EXTRUDED SELF-CLUMPING ANIMAL LITTER | PIONEER PET PRODUCTS LLC (US) | 2020-06-17 | — | — | EP | disclosed |
| CN-107583623-B | Method for manufacturing cat litter | 先锋宠物用品有限责任公司 | 2020-04-07 | — | — | CN | disclosed |
| EP-1364958-A1 | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF | Kissei Pharmaceutical Co., Ltd. (JP) | 2003-11-26 | — | — | EP | disclosed |
| EP-1354888-A1 | GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND USE THEREOF IN MEDICINES | Kissei Pharmaceutical Co., Ltd. (JP) | 2003-10-22 | — | — | EP | disclosed |
| US-6602902-B2 | Targeting a pharmaceutical agent to a noncentral nervous system tissue by administering a covalent conjugate of the drug and cis-docosahexanoic acid | PROTARGA, INC. | 2003-08-05 | — | — | US | disclosed |
| US-6576636-B2 | Treating a noncentral nervous system by administering a covalent conjugate of a C8-26, unbranched, naturally occurring fatty acid and a drug, provided the drug is not an adenosine receptor agonist/antagonist; anticarcinogenics | PROTARGA, INC. | 2003-06-10 | — | — | US | disclosed |
| US-20030059471-A1 | Oral delivery formulation | COMPTON BRUCE JON (US) | 2003-03-27 | — | — | US | disclosed |
| US-20020010208-A1 | Targeting a pharmaceutical agent to a noncentral nervous system tissue by administering a covalent conjugate of the drug and cis-docosahexanoic acid | LUITPOLD PHARMACEUTICALS, INC. | 2002-01-24 | — | — | US | disclosed |
| US-20010002404-A1 | Fatty acid-pharmaceutical agent conjugates | LUITPOLD PHARMACEUTICALS, INC. | 2001-05-31 | — | — | US | disclosed |
| WO-1999030690-A1 | ORAL DELIVERY FORMULATION | AXIA THERAPEUTICS, INC. (US) | 1999-06-24 | — | — | WO | disclosed |
| US-5795909-A | ANTICARCINOGENIC AND ANTITUMOR AGENTS; BREAST, COLON, OVARIANCANCERS | NEUROMEDICA, INC. (US) | 1998-08-18 | — | — | US | disclosed |
| US-5118679-A | Using organogermanium compound | ASAI GERMANIUM RESEARCH INSTITUTE CO., LTD. (JP) | 1992-06-02 | — | — | US | disclosed |